Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed1
Recruiting1
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04322318Phase 2Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms TumorRecurrent Kidney Wilms TumorStage II Kidney Wilms Tumor+2 more
PrincipalinvestigatorStart date: 2020-10-19
NCT03595124Phase 2Active Not Recruiting
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)
Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8+2 more
PrincipalinvestigatorStart date: 2019-01-08
NCT02452554Phase 2Completed
Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma
Pleuropulmonary BlastomaRecurrent Malignant Peripheral Nerve Sheath TumorRecurrent Neuroblastoma+3 more
PrincipalinvestigatorStart date: 2015-10-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Sumanta K Pal

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Stage IV Renal Cell Cancer AJCC v8Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Chad Tang

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Siqing Fu, MD, PhD

M.D. Anderson Cancer Center

Related
6 trials

Shared therapeutic areas:

Stage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8
Similarity Score4%

AeRang Kim, MD, PhD

Children's National Research Institute

Related
7 trials

Shared therapeutic areas:

Wilms Tumor
Similarity Score2%

Theodore Logan, MD

Indiana University

Related
2 trials

Shared therapeutic areas:

Metastatic Renal Cell Carcinoma
Similarity Score2%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Wilms Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Maryam Fouladi

Children's Oncology Group

Related
5 trials

Shared therapeutic areas:

Recurrent Neuroblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04322318Phase 2PrincipalInvestigator

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms TumorRecurrent Kidney Wilms TumorStage II Kidney Wilms Tumor+2 more
Recruiting
NCT03595124Phase 2PrincipalInvestigator

A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)

Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8+2 more
Active Not Recruiting
NCT02452554Phase 2PrincipalInvestigator

Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

Pleuropulmonary BlastomaRecurrent Malignant Peripheral Nerve Sheath TumorRecurrent Neuroblastoma+3 more
Completed

All 3 trials loaded